Spread through air spaces as a prognostic factor in resected non-small cell lung cancer

Aims: To evaluate the prognostic impact of spread through air spaces (STAS) in patients with resected non-small cell lung cancer (NSCLC) and to investigate its association with clinicopathological features and survival outcomes. Methods: A retrospective analysis was conducted on 207 patients with pathological stage IA–IIIA NSCLC who underwent curative-intent surgery between 2018 and 2024. STAS was defined as the presence of micropapillary clusters, solid nests, or single tumor cells within alveolar spaces beyond the main tumor. Patients were categorized as STAS-positive or STAS-negative. Disease free survival (DFS) and overall survival (OS) were estimated using the Kaplan–Meier method. Univariate and multivariate Cox regression models were used to assess prognostic factors. Results: STAS was identified in 57% of patients. STAS positivity was significantly associated with poor differentiation, a higher rate of lymphovascular invasion, and increased use of adjuvant chemotherapy. Median DFS was 29.9 months in STAS-positive patients but was not reached in STAS-negative patients (p

Authors

Institutions

Publication Details

Journal
Anatolian Current Medical Journal
Published
2025-09-15
DOI
https://doi.org/10.38053/acmj.1738996
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spread through air spaces as a prognostic factor in resected non-small cell lung cancer

İsmail Ertürk, Elçin Kadan, Musa Barış Aykan, Ersin Sapmaz et al.
Anatolian Current Medical Journal
Lung Cancer Diagnosis and Treatment
article

Spread through air spaces as a prognostic factor in resected non-small cell lung cancer

İsmail Ertürk, Elçin Kadan, Musa Barış Aykan, Ersin Sapmaz, Nuri Karadurmuş, Volkan Aslan, Gül Sema Yıldıran Keskin, Gizem Yıldırım
article en

Abstract

Aims: To evaluate the prognostic impact of spread through air spaces (STAS) in patients with resected non-small cell lung cancer (NSCLC) and to investigate its association with clinicopathological features and survival outcomes. Methods: A retrospective analysis was conducted on 207 patients with pathological stage IA–IIIA NSCLC who underwent curative-intent surgery between 2018 and 2024. STAS was defined as the presence of micropapillary clusters, solid nests, or single tumor cells within alveolar spaces beyond the main tumor. Patients were categorized as STAS-positive or STAS-negative. Disease free survival (DFS) and overall survival (OS) were estimated using the Kaplan–Meier method. Univariate and multivariate Cox regression models were used to assess prognostic factors. Results: STAS was identified in 57% of patients. STAS positivity was significantly associated with poor differentiation, a higher rate of lymphovascular invasion, and increased use of adjuvant chemotherapy. Median DFS was 29.9 months in STAS-positive patients but was not reached in STAS-negative patients (p

Anatolian Current Medical JournalVol. 7(5)
New York Academy of Medicine (US), University of Health Sciences (SO)
Openalex Percentile: Top 63%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.